Partner with Us
Linear Motion 120, LLC is looking for an individual or company with whom we can collaborate to bring the Linear Motion 120 with HyperX device (LM 120 with HyperX) to the consumer. Read on to find out how you can benefit from a partnership with us.
Hi, my name is Lawrence Guillen. While working for 10 years as a fitness trainer in a physical therapy clinic, I invented and patented a medical device that will help clients restore their knee range of motion (ROM) after total knee replacement (TKR) surgery. The LM 120 with HyperX apparatus is an adjunct to manual manipulation, as practiced in the physical therapy clinic.
WHAT ISSUES WE ARE ADDRESSING WITH OUR DEVICE
Each year over 700 thousand people undergo total knee replacement surgery. The average age of clients is 65. Medicare is willing to pay $2100 for the physical rehabilitation for these individuals, which translates conservatively to a national cost of 1.4 billion dollars. Mechanical rehab devices currently in use are allotted by Medicare an average of $1400 for a 21-day rental, totaling almost 290 million dollars yearly. In the last 10 years, there has been a 60% increase in TKR surgeries. If this average growth rate continues, we would expect to see more than 1.2 million total knee replacement surgeries by 2030.
Unfortunately up to 20% of these surgeries and their rehab regimens result in poor outcomes, such as limping or poor gait. Clients are often unable to resume the normal activities of daily living, such as getting out of a vehicle or climbing stairs. The LM 120 with HyperX has been engineered to overcome the deficiencies found in the only mechanical rehabilitation device found in the marketplace, the continuous passive motion (CPM) machine. The CPM design has remained essentially unchanged since its introduction in the 1970s. The CPM has been discredited through multiple clinical trials as ineffective except to lift the leg.
WHY THE FDA HAS GIVEN US THE GREEN LIGHT TO GO TO MARKET
Our team of mechanical and electrical engineers and I have designed, fabricated and manufactured an apparatus that is market-ready for immediate use in clients’ homes and physical therapy clinics. The LM 120 with HyperX has undergone FDA scrutiny to be rated as a Class I Medical Device, with CAD drawings, Bills of Material and a custom electronic and software package to which our company holds the design rights. We possess a U.S. utility patent on the original design and a provisional patent reflecting upgrades.
Our apparatus offers significant benefits as a rehab instrument. The LM 120 with HyperX is user-friendly, accurate and safe. The unit is easy to set-up in the home, consisting of two separate pieces, together weighing less than 33 pounds. During therapy, clients are able to stop, pause, reverse or resume when they experience pain. Clients also feel in control when they can collaborate with physical therapy staff to set and reach treatment goals, thus helping to determine the pace at which recovery can occur. Although our device is intended to be used after TKR surgery, we have been exploring how our apparatus with continuous motion and hip engagement might be appropriate for exercise by individuals with motion diseases such as Parkinson’s and multiple sclerosis.
Our state-of-the-art electronic and software package ensures that degrees of flexion (bending) and extension (straightening) are accurately depicted and recorded on the hand-held Tablet screen and subsequently emailed to the PT clinic. This digital communication between patient and provider is known as Remote Therapeutic Monitoring (RTM). RTM enables healthcare professionals to remotely monitor and manage clients’ progress and treatment plans outside of traditional in-person sessions. The Centers for Medicare and Medicaid Services (CMS) approved this tool and billing protocol for PT practices in its Final Rule 2025.
Mechanical, electrical and electronic safety features include standard limit switches on the three motors and heat sensitive touch controls on the Tablet screen. Unique to the unit is a kick-out Foot Pedal that allows the client to exit quickly in the event of cramp.
WHO WILL BENEFIT FROM OUR DEVICE
It is obvious that the end-user of the LM 120 with HyperX is the individual TKR patient. During a pilot study we conducted to test the efficacy and reliability of the device, we identified JV, a 67-year-old businessman. JV set aside 21 days to heal and recover from surgery. He meticulously followed the LM 120’s protocol of four daily sessions of 15-20 minutes each. Also, he adhered to the usual and customary physical therapy clinic routine: three weekly rehab sessions and daily PT home exercises. Because of his diligence, he was discharged by the PT clinic and his orthopedic surgeon well within the 21 days allotted by Medicare for reimbursement. He reported satisfaction with, and credited the device for, his speedy recovery.
While clients stand to benefit from using our device, physical therapy practices can profit if our device is utilized on-site. With less painful manual manipulation, the clinic can expect fewer treatment discontinuations resulting in fewer crippling contractures. PT staff can shift the focus of clinic time from manual manipulation to achieve ROM to gait, balance and strengthening activities. Clinic appointment slots previously filled with flexion/extension therapy can be reallocated to other clients, increasing overall clinic productivity. Clinic owners can reap the benefits afforded through our RTM electronic capabilities. CMS now recognizes and has established CPT codes to cover billing for home-based unit set-up and training for family members, friends and neighbors who assist with daily therapy sessions. Office staff can collect, analyze and make transmitted client data readily available and billable. Practices could generate $200-$400 additional monthly revenue per qualifying patient through caregiver training alone.
HOW WE CAN ADVANCE OUR COMPANY WITH YOUR COLLABORATION
We have multiple options to proceed forward in the evolution of our Company. We may elect to establish a FDA-compliant facility to manufacture the units and to distribute our exemplary product as a durable medical device retailer. Each resource mentioned lists the market size predicted to be achieved by 2030: 1) U.S. hospital and health systems with orthopedic programs (USD 2,540.4 billion); 2) home health agencies (USD 747.70 billion); or 3) group physical therapy clinics (USD 70 billion). A second option is to manufacture and distribute the LM 120 with HyperX as a durable medical device wholesaler to the medical equipment rental industry, with a market size predicted to reach USD 86.2 billion by 2030.
Alternatively, we could select a firm to manufacture and distribute the device, with either outright purchase of Company assets or negotiate a licensing agreement with royalties. The resources available include the market size predicted to be achieved by 2039-2034: 1) global medical device manufacturers (USD 800 billion); 2) rehabilitation equipment manufacturers (USD 37.34 billion); 3) fitness and gym equipment manufacturers (USD 17.7 billion); 4) CPM manufacturers (3,015.96 million); or 5) private investors such as conglomerate orthopedic surgeons’ practices or group physical therapy clinics contacted at trade and professional conferences.
Now that you know the WHAT, WHY, WHO and HOW of the LM 120 with HyperX……
WHEN YOU SHOULD RESPOND TO OUR APPEAL
Now is the time for you to step up to bring this innovative product to the consumer so that we can profit together in this high potential arena. Let us answer your questions or arrange to meet to discuss issues in more detail.
Thank you for your interest!